Literature DB >> 32871043

Prognostic scoring system and risk stratification in patients with emphysematous pyelonephritis: an 11-year prospective study at a tertiary referral centre.

Sriram Krishnamoorthy1, Alimuddin Zumla2,3, Hariharasudhan Sekar1, Asif Muneer4, Gayathri Thiruvengadam5, Natarajan Kumaresan1.   

Abstract

OBJECTIVES: To define pre-morbid, clinical, laboratory, and imaging features and identify prognostic factors associated with morbidity and mortality in patients with emphysematous pyelonephritis (EPN) and develop a prognostic scoring system for improving management outcomes. PATIENTS AND METHODS: From January 2009 to December 2019, we performed a prospective study of all patients with a suspected diagnosis of EPN referred to a specialist tertiary centre in South India. All patients who underwent non-contrast computed tomography of the abdomen and those diagnosed with EPN were included in this study. Demographic parameters, imaging, haematological and microbiology results were recorded. Patients were divided into three groups: Group 1, patients who survived without any intervention; Group 2, those who survived with surgical intervention; and Group 3, those who died with or without intervention. A prognostic scoring system was developed from 18 different parameters and risk stratification was developed. The scores were correlated with overall prognosis.
RESULTS: Data from 131 patients with EPN enrolled in the study were analysed: Group 1 (n = 22), Group 2 (n = 102) and Group 3 (n = 7). By using univariate analysis, 10 factors were identified to be significantly associated with prognosis. Diabetes mellitus was the most common comorbidity. Shock at initial admission indicated a poor prognosis and warranted immediate attention (P < 0.001).
CONCLUSIONS: A multi-disciplinary approach, a high index of clinical suspicion, an early diagnosis and administration of culture-specific antibiotics with identification of prognostic indicators and risk stratification, allows prompt and appropriate medical and surgical treatments that could improve EPN management outcomes.
© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  #UroUTI; diabetes mellitus; emphysematous pyelonephritis; haemodialysis; nephrectomy; percutaneous nephrostomy

Year:  2020        PMID: 32871043     DOI: 10.1111/bju.15225

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  4 in total

Review 1.  Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis.

Authors:  Xuan Thai Ngo; Tuan Thanh Nguyen; Ryan W Dobbs; Minh Sam Thai; Duc Huy Vu; Le Quy Van Dinh; Khoa Quy; Hieu Trong Le; Tien-Dat Hoang; Hanh Thi Tuyet Ngo; Trinh Ngoc Khanh Van; Ho Yee Tiong; Huy Gia Vuong
Journal:  World J Surg       Date:  2022-07-08       Impact factor: 3.282

2.  Emphysematous pyelonephritis: Six case reports and review of literature.

Authors:  Li-Ping Ma; Ning Zhou; Yan Fu; Yan Liu; Cong Wang; Bin Zhao
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

3.  Evaluation of early scoring predictors for expedited care in patients with emphysematous pyelonephritis.

Authors:  Arun Chawla; Sunil Pillai Bhaskara; Ravi Taori; Jean J M C H de la Rosette; Pilar Laguna; Akhilesh Pandey; Sitaram Mummalaneni; Padmaraj Hegde; Shwetapriya Rao; Prakashini K
Journal:  Ther Adv Urol       Date:  2022-02-22

4.  Percutaneous Nephrostomy in Complicated Urinary Tract Infections.

Authors:  Utsav Mondal; Stalin Viswanathan; Sreerag Sreenivasan Kodakkattil
Journal:  Cureus       Date:  2022-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.